-
Snell & Wilmer Product Liability Group
Experienced trial attorneys. Trusted advisors. Counseling companies across the country and throughout their products' lifecycles.
Click the map below to expand.
-
Follow us on Twitter
-
Recent Posts
Topics
- asbestos
- automotive
- autonomous vehicles
- biosimilar
- consumer products
- CPSC
- cybersecurity
- damages
- FDA
- food
- guidance
- Internet of Things
- jury
- litigation
- medical
- medical devices
- mobile
- NHTSA
- pharmaceutical
- privacy
- products
- recalls
- Trials
- Trucking/transportation
- Uncategorized
- unmanned aircraft systems/"drones"
- verdicts
FDA Approves Second Biosimilar – Inflectra™ – The First Monoclonal Antibody Biosimilar
The U.S. Food and Drug Administration announced on April 5 its second ever approval of a biosimilar – Inflectra (infliximab-dyyb) – for multiple indications. Inflectra was developed by Celltrion Inc. and licensed to Pfizer Inc., for treatment of rheumatoid arthritis, … Continue reading
Posted in biosimilar, FDA, pharmaceutical
Share this Article:
Arizona Supreme Court Adopts Learned Intermediary Doctrine
The Arizona Supreme Court has issued an opinion adopting the learned intermediary doctrine in Arizona. The Supreme Court rejected the Arizona Court of Appeals’ earlier decision holding that the learned intermediary doctrine was incompatible with the Uniform Contribution Among Tortfeasors … Continue reading
Posted in medical devices, pharmaceutical
Share this Article:
Arizona Supreme Court Poised to Consider “Learned Intermediary” Doctrine
The Arizona Supreme Court has agreed to hear an appeal of the Court of Appeals’ January 2015 decision regarding the longstanding “learned intermediary” doctrine. In January, the lower court held that the doctrine was inconsistent with Arizona’s system of pure … Continue reading
Posted in FDA, pharmaceutical
Share this Article:
Product Recall Trends in 2015
What are the latest trends on product recalls in the United States? Stericycle ExpertSOLUTIONS writes an interesting and informative quarterly report on this data, and its detail on the first quarter of 2015 is here. Consumer Products. The Consumer Product … Continue reading
Posted in automotive, consumer products, FDA, medical devices, pharmaceutical, recalls
Share this Article:
The Learned Intermediary Defense Advances in Nevada
The learned intermediary doctrine can be a legal defense against product liability claims. It is most commonly applied in cases involving drugs and medical devices. A learned intermediary is a medical expert, such as a prescribing physician, who can weigh … Continue reading
Posted in litigation, medical devices, pharmaceutical
Share this Article:
FDA Issues Draft Guidance on Distributing New Risk Information for Approved Drugs and Biologics
In June 2014, the U.S. Food and Drug Administration (FDA) issued a draft guidance for the distribution of new risk information for approved prescription drugs to healthcare professionals and healthcare entities. The draft guidance, entitled Guidance for Industry Distributing Scientific … Continue reading
Posted in FDA, pharmaceutical
Share this Article:
Summary of FDA’s Final Guidance on Dear Health Care Provider Letters
At the beginning of this year, the Food and Drug Administration (FDA) issued its final guidance on the content and format of Dear Health Care Provider (DHCP) letters. DHCP letters are correspondence, often in the form of a mass mailing … Continue reading
Posted in consumer products, FDA, guidance, medical, pharmaceutical, Uncategorized
Share this Article:
Drug and Device Manufacturers Beware: Comments Could Result in FDA Troubles
After appearing on CNBC television show Fast Money, the CEO of Aegerion Pharmaceuticals received a warning letter from the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion. The agency asserted that comments made on the show … Continue reading
Posted in FDA, pharmaceutical, Uncategorized
Share this Article:
Product Recall Trends and How to Prepare for a Recall
Product recalls are more common than ever. We see recall announcements virtually every week. Consumers have come to expect them, and to expect that companies will act quickly and decisively when a product risk is identified. Most recalls today are … Continue reading
Posted in consumer products, CPSC, FDA, food, medical devices, pharmaceutical, products, recalls
Share this Article:
